申请人:PFIZER INC.
公开号:EP0138464A2
公开(公告)日:1985-04-24
Novel 2-amino-5-hydroxy-4-methylpyrimidines and substituted amino derivatives thereof useful as inhibitors of leukotriene synthesis for the treatment of pulmonary, inflammatory and cardiovascular diseases, cancer and psoriasis. In addition these compounds are cytoprotective and therefore useful in the treatment of peptic ulcers. A process for the preparation of such active compounds by ring rearrangement of 2-amino-5-acetyloxazole, pharmaceutical compositions containing the novel active compounds and compositions containing these compounds in combination with other anti-inflammatory agents or gastric anti-secret- t ory agents.
新型 2-氨基-5-羟基-4-甲基嘧啶及其取代氨基衍生物可作为白三烯合成抑制剂,用于治疗肺病、炎症性疾病、心血管疾病、癌症和牛皮癣。此外,这些化合物还具有细胞保护作用,因此可用于治疗消化性溃疡。通过 2-氨基-5-乙酰基恶唑的环重排制备此类活性化合物的工艺,含有新型活性化合物的药物组合物,以及含有这些化合物与其他消炎药或抗胃泌素药组合的组合物。